Gauthier S
Unité de recherche sur la maladie d'Alzheimer, Centre McGill d'études sur le vieillissement, Québec, Canada H4H 1R3.
Rev Neurol (Paris). 2004 Feb;160(2):261-4. doi: 10.1016/s0035-3787(04)70901-7.
The availability of many etiological hypothesis for Alzheimer's disease raise the possibility of treatments aiming at slowing down disease progression. Clinical trial designs and relevant outcomes are available to test these hypothesis. A preventive approach based on individual risk assessment may be possible, which will increase the number of consultations for neurologists in the near future.
针对阿尔茨海默病的多种病因假说的存在，增加了旨在减缓疾病进展的治疗方法的可能性。有临床试验设计和相关结果可用于检验这些假说。基于个体风险评估的预防方法或许可行，这将在不久的将来增加神经科医生的会诊数量。
